Lamivudine Monotherapy in HIV-1-Infected Patients Harbouring a Lamivudine-Resistant Virus: A Randomized Pilot Study (E-184V Study)

In people with HIV harboring a 3TC-resistant virus, does 3TC monotherapy lead to better immunological and clinical outcome than complete therapy interruption?

Continue to Lamivudine Monotherapy in HIV-1-Infected Patients Harbouring a Lamivudine-Resistant Virus: A Randomized Pilot Study (E-184V Study) on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz